Ian Clements, Chief Financial Officer at Mirum Pharmaceuticals, Inc. (MIRM), bought 1,450 shares at $14.40 ($21K) on 2021-11-24, disclosed to the SEC on 2021-11-29.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $14.40 | 700 | $10K | 49.2% |
| 2 | $13.90 | 750 | $10K | 50.8% |
| Total | $14.14 avg | 1,450 | $21K | 100% |
| Filing → |
| MIRM | BUY | 2020-12-28 | $46K | — | Filing → |
| MIRM | BUY | 2019-09-10 | $46K | — | Filing → |